Lobbying client · LD-2 disclosures
Fabiani & Company on Behalf Alnylam Pharmaceuticals
District of Columbia
8 filings from 1 registrant · 2009–2012 · latest filed Apr 14, 2012
Reported on its behalf
$0
every LD-2 on file
Its own filed spend
$0
lobbying for itself
Fees to outside firms
$0
none reported
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Copyright/Patent/Trademark
CPT
7 filings
Health Issues
HCR
4 filings
Pharmacy
PHA
1 filing
Bills named in the filings
Every bill reference extracted from the filings' activity descriptions.
- S. 515 111th CongressNamed in the filings; no matching bill record on file.4 filingsthrough 2009
- H.R. 3590 111th CongressNamed in the filings; no matching bill record on file.3 filingsthrough 2010
How these are found · Bill references are extracted from the free-text activity description each filing writes, then matched to the Congress in session that filing year. A reference we can't match to a bill on file is still shown, unlinked — we cite what the filing said rather than guess at what it meant. Naming a bill is not a position on it: LD-2 records that a client lobbied on the bill, never which side.
Who did the lobbying
Every lobbyist named on this client's filings.
- Danielle Organ Peters Danielle Organ Peters11 filingsthrough 2011
The filings
Every filing on record. Each row links to its full disclosure.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: fabiani-company-on-behalf-alnylam-pharmaceuticals.